Hematocrit/Microhematocrit
The Hematocrit (Hct) represents the percentage of a person's blood volume occupied by red blood cells (RBCs). Blood, also known in the laboratory as peripheral blood or whole blood, is composed of a liquid component (plasma) and a cellular component (white blood cells, platelets, and RBCs). RBCs make up the largest portion of the cellular component and are mainly responsible for carrying oxygen (O2) from the lungs to the various tissues throughout the body. RBCs do this by binding the O2 molecules to hemoglobin (see hemoglobin) via an iron molecule. When the number of RBCs is decreased, a corresponding decrease of O2 to the tissues occurs, resulting in a number of clinical manifestations. An increase in the number of RBCs can also be problematic, mainly due to excess iron, which can accumulate in the tissues causing damage. Determining the percentage of RBCs in the blood is an important aid to the physician in the diagnosis of disease.
Laboratories use several methods to determine a hematocrit value. Automated instrumentation may be able to measure the hematocrit directly, or calculate it using the obtained RBC value and the measured MCV (mean corpuscular volume). The formula used to calculate the hematocrit using the RBC and the MCV is HCT = RBC X MCV/10. The hematocrit may also be determined manually by taking a sample of the patient’s blood, placing it in a capillary tube, centrifuging the tube, and determining the percentage of the tube containing RBCs by visual inspection. This method is usually referred to as a microhematocrit. HCT is synonymous with Red Cell Volume (RCV) and Packed Cell Volume (PCV).
- Diagnosis of anemia(s)
- Diagnosis of polycythemia, primary or secondary
- Evaluation of bleeding disorders
- Diagnosis of acute hemorrhage
- Evaluation of thalassemias
Increased in:
- Polycythemia vera (a chronic myeloproliferative disorder)
- Secondary polycythemia
- Hemoconcentration such as dehydration, burns, vomiting, and extreme physical exercise, in higher altitude
Decreased in:
- Anemias
- Bleeding
- Normocytic anemia due to iron deficiency
- Anemia of chronic disease
- Hemolytic anemia
- Acute hemorrhage
- Microcytic anemia due to iron deficiency
- Thalassemia
| Unit: Volume Fraction (%) | ||
| Age / Sex | % | Fraction |
| Cord blood | 42–60 | 0.42–0.60 |
| 0.5 mo | 41–65 | 0.41–0.65 |
| 1 mo | 33–55 | 0.33–0.55 |
| 2 mo | 28–42 | 0.28–0.42 |
| 4 mo | 32–44 | 0.32–0.44 |
| 6 mo | 31–41 | 0.31–0.41 |
| 9 mo | 32–40 | 0.32–0.40 |
| 12 mo | 33–41 | 0.33–0.41 |
| 1–2 yr | 32–40 | 0.32–0.40 |
| Blood | ||
| 3–5 yr | 32–42 | 0.32–0.42 |
| 6–8 yr | 33–41 | 0.33–0.41 |
| 9–11 yr | 34–43 | 0.34–0.43 |
| 12–14 yr Male | 35–45 | 0.35–0.45 |
| 12–14 yr Female | 34–44 | 0.34–0.44 |
| 15–17 yr Male | 37–48 | 0.37–0.48 |
| 15–17 yr Female | 34–44 | 0.34–0.44 |
| 18–44 yr Male | 39–49 | 0.39–0.49 |
| 18–44 yr Female | 35–45 | 0.35–0.45 |
| 45–64 yr Male | 39–50 | 0.39–0.50 |
| 45–64 yr Female | 35–47 | 0.35–0.47 |
| 65–74 yr Male | 37–51 | 0.37–0.51 |
| 65–74 yr Female | 35–47 | 0.35–0.47 |
Whole Blood EDTA (Lavender).
Stability
- Ambient: 48 hours
1-3 days.
- Anesth Analg. 2011 Dec 9. [PMID: 22156329]
- Clin Nephrol. 2002;58:S58. [PMID: 12227728]
- Crit Care Med. 2006;34:S102. [PMID: 16617252]
- Jacobs, David S., DeMott, Wayne R., (2001). Laboratory Test Handbook. 5th. Hudson, OH. Lexi-Comp, Inc.